完整後設資料紀錄
DC 欄位語言
dc.contributor.authorChen, Peng-Shengen_US
dc.contributor.authorChen, Lan S.en_US
dc.contributor.authorFishbein, Michael C.en_US
dc.contributor.authorLin, Shien-Fongen_US
dc.contributor.authorNattel, Stanleyen_US
dc.date.accessioned2014-12-08T15:36:08Z-
dc.date.available2014-12-08T15:36:08Z-
dc.date.issued2014-04-25en_US
dc.identifier.issn0009-7330en_US
dc.identifier.urihttp://dx.doi.org/10.1161/CIRCRESAHA.114.303772en_US
dc.identifier.urihttp://hdl.handle.net/11536/24474-
dc.description.abstractAutonomic nervous system activation can induce significant and heterogeneous changes of atrial electrophysiology and induce atrial tachyarrhythmias, including atrial tachycardia and atrial fibrillation (AF). The importance of the autonomic nervous system in atrial arrhythmogenesis is also supported by circadian variation in the incidence of symptomatic AF in humans. Methods that reduce autonomic innervation or outflow have been shown to reduce the incidence of spontaneous or induced atrial arrhythmias, suggesting that neuromodulation may be helpful in controlling AF. In this review, we focus on the relationship between the autonomic nervous system and the pathophysiology of AF and the potential benefit and limitations of neuromodulation in the management of this arrhythmia. We conclude that autonomic nerve activity plays an important role in the initiation and maintenance of AF, and modulating autonomic nerve function may contribute to AF control. Potential therapeutic applications include ganglionated plexus ablation, renal sympathetic denervation, cervical vagal nerve stimulation, baroreflex stimulation, cutaneous stimulation, novel drug approaches, and biological therapies. Although the role of the autonomic nervous system has long been recognized, new science and new technologies promise exciting prospects for the future.en_US
dc.language.isoen_USen_US
dc.subjectheart failureen_US
dc.subjectmyocardial infarctionen_US
dc.titleRole of the Autonomic Nervous System in Atrial Fibrillation Pathophysiology and Therapyen_US
dc.typeArticleen_US
dc.identifier.doi10.1161/CIRCRESAHA.114.303772en_US
dc.identifier.journalCIRCULATION RESEARCHen_US
dc.citation.volume114en_US
dc.citation.issue9en_US
dc.citation.spage1500en_US
dc.citation.epage1515en_US
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000335596000016-
dc.citation.woscount15-
顯示於類別:期刊論文